Northeastern University’s Pharmaceutical Industry Fellowship Program is a two-year fellowship designed to advance the education and training of Pharm.D. graduates in various areas of industry pharmacy including regulatory affairs, medical information/affairs, patient safety, outcomes research, and many other areas. The program is a collaboration between Northeastern University and biopharmaceutical industry partners.
Our program provides a dynamic academic environment offering fellows the opportunity for a wide breadth of experiences:
Develop teaching skills through participation in our Teaching and Learning Seminar series
Facilitate small and large group didactic education in partnership with a faculty mentor
Create, present, and publish scholarly research through collaborative industry and university relationships
Engage with faculty who participate in various interdisciplinary
Network with area residents and other Northeastern fellows via professional development programs, teaching seminars, and participation on fellowship committees
In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year US Medical Affairs PharmD fellowship based in Cambridge, Massachusetts.
We are not accepting PPS interview requests. Applicants must apply through our career portal to be considered for this position. Apply today using the link at the end of this posting!
About Alnylam Pharmaceuticals:
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.
US Medical Affairs translates and implements the disease and product strategy set at the global level and adapts it to the US healthcare landscape. US Medical works within a cross-functional and strategic matrix team building tactical alignment with internal partners (Clinical Operations, Commercial, Legal, Regulatory, Compliance, Global Medical Excellence, Publications, Patient Advocacy) and delivers on the medical plan. With a deep understanding of the treatment landscape, disease landscape and provider mindset, US Medical directors play a key role in informing global product development and data generation strategies with perspective of US Region. The team also provides disease and product education to both internal stakeholders (Commercial, sales, new employees) as well as the external healthcare community. Field medical teams within US Medical engage in scientific discussions with both HCPs and payers to collect and disseminate evolving insights on the external treatment landscape, Alnylam’s clinical trial programs, and Alnylam data to inform Alnylam strategy.
The US Medical Fellow will support the development and pull through of scientific presentations to support upcoming launch activities. The fellow will also have a chance to shadow MSLs and understand the principles of engagement with HCPs, gathering insights and leading scientific discussions. Working closely with the Senior Medical Director of US Medical, the Fellow will have the opportunity to develop, lead, and implement projects to support medical excellence and value metrics across the whole department.
Contribute to the tactical planning and execution of US Medical Affairs plans
Understand patient pathways, care gaps, and HCP education needs in different US geographies
Support development of regional field medical plans across specified rare and TTR disease areas and programs
Support the medical plan for the ongoing evolution of Alnylam and its products (patisiran and vutirsiran) in the ATTR amyloidosis space
Support the development and/or pull-through of US-specific medical communications, publications, and training of materials including slide decks, infographics, abstracts, digital assets, posters, and articles
Support, as needed, other key US-specific Medical Affairs projects or initiatives
Develop new opportunities within Medical Affairs to expand to additional experiences tailored to your career goals
Doctor of Pharmacy degree from an ACPE accredited institution, eligible for licensure as a pharmacist in the State of Massachusetts.
Excellent oral and written communication, time management, and leadership skills, ability to work independently and take initiative on a variety of projects at the industry site and Northeastern.
Applicants should submit the following APPLICATION MATERIALS by the priority deadline of October 31, 2023
Curriculum vitae (CV), uploaded
Unofficial PharmD transcripts, uploaded
Cover letter, uploaded
Three formal letters of recommendation (LORs) sent directly from the letter writer to PharmDFellowships@northeastern.edu by November 29th , 2023. LOR writers should include the candidate’s name and fellowship program(s) in the subject line (e.g. Smith, John – Alnylam, GSK).
Address cover letter and three LORs to:
J. Andrew Orr-Skirvin, PharmD, BCOP
Clinical Professor, School of Pharmacy
Chair, Department of Pharmacy & Health System Sciences
Director of Pharmaceutical Industry Fellowship Program
Northeastern University Pharmaceutical Industry Fellowships Program offers a variety of two-year post-PharmD research fellowships. We aim to provide fellows with a dynamic environment to develop industry and academic skills to be leaders in their fields.
With the rich biopharmaceutical landscape of Greater Boston as a backdrop, our programs offer the fellow an opportunity to work with innovative industry partners in a variety of specialty areas while partnering with Northeastern University faculty in the areas of research, scholarship, and teaching.